Page 2 - Life Science

Life sciences firm Tarsons Products sets IPO price band at Rs 635-662/share

Leading life sciences company Tarsons Products on Wednesday said it has fixed a price band of Rs 635-662 a share for its Rs 1,024-crore initial share-sale. The three-day initial public offering (IPO) will open on November 15 and conclude on November 17. The bidding for anchor investors will open on November 12, the company announced. The initial share-sale comprises fresh issuance of equity shares worth Rs 150 crore and an offer for sale (OFS) of 1.32 crore equity shares by promoters and an investor. As a part of the OFS, promoters -- Sanjive Sehgal will offload up to 3.9 lakh equity shares and Rohan Sehgal will sell up to 3.1 lakh equity shares -- and investor Clear Vision Investment Holdings Pte Ltd will divest up to 1.25 crore equity shares. At the upper end of the price band, the IPO is expected to fetch Rs 1,024 crore. The public issue will include a reservation of 60,000 equity shares for employees. ICICI Securities, Edelweiss Financial Services and SBI Capital Markets are

Life sciences company Tarsons Products' IPO to open on November 15

The initial share sale of life sciences company Tarsons will open for public subscription on November 15.

HCL Tech, Google Cloud expand tie up for healthcare, life science solutions

HCL Technologies on Monday said it has expanded its strategic partnership with Google Cloud to jointly launch healthcare and life sciences solutions for customers

DCGI nod to phase-I clinical trial of Reliance Life Sciences' Covid vaccine

DCGI on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said.

Life sciences firm Bayer launches consumer health division in India

The division will strengthen Bayer's presence in India

Anupam Rasayan bags orders worth Rs 540 cr to supply speciality chemicals

Anupam Rasayan on Wednesday said it has bagged orders worth Rs 540 crore from two multinational companies for supplying speciality chemicals

MediBuddy raises $20mn funding from India Life Sciences Fund III, others

The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others

Life sciences is the next logical area for India: Blackstone CEO

CEO Stephen A Schwarzman spoke to Pavan Lall in a video chat about the future of commercial realty in India, recovery from a global recession, India's return to growth path, Covid-19 vaccine and more

Scientists identify two antibodies from llamas that can neutralise Covid-19

According to the researchers, these small antibodies are currently being developed against SARS-CoV-2 as research tools and potential therapeutics

India's healthcare system might struggle to keep pace by 2030, says report

Doctors are looking for multiple types of support to manage the complexity-with 85 per cent of doctors upgrading their own clinical skills

PerkinElmer to realign business into two segments

Prahlad Singh to lead the diagnostics business, while Jim Corbett to head the discovery & analytical solutions business